Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EOS Health vs PauseRX

EOS Health
Graded #269

Lower grade

vs+5.700000000000003
PauseRX
Graded #150

Higher grade

The verdict

PauseRX takes it — 68.5/100 to 62.8/100.

PauseRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PauseRX is a nationwide compounded GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePauseRX +22
44
66
Dose & formulationPauseRX +21
64
85
Clinical oversightEOS Health +4
87
83
Labs & monitoringEOS Health +14
66
52
FulfillmentEOS Health +23
84
61
Contract termsPauseRX +21
20
41
EOS Health · left barPauseRX · right bar

The numbers

MetricEOS HealthPauseRX
WeighScore62.8/10068.5/100
GradeCC
Scorecard rank#269#150
Semaglutide$199/mo (compounded)$199/mo
Tirzepatide$289/mo (compounded)$249/mo (starting dose, compounded)
Coverage40 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
EOS Health

Graded #269 · C

Strengths

  • Unusually transparent: publicly names its clinical partner (Arora Health & Aesthetics, LLC) and pharmacy partner (F&F Pharmacies dba Jungle Jim's)
  • Competitive compounded pricing from $199/mo semaglutide and $289/mo tirzepatide, plus $100 off the first prescription with code WELCOME100
  • Multiple compounded formulas (semaglutide, semaglutide+glycine, semaglutide+B12, tirzepatide) and optional 130+ biomarker lab add-ons
  • Free expedited shipping, no insurance required, 10-minute intake, and an ongoing care team via patient portal

Where it loses points

  • Available in only 40 states — not offered in CA, NV, NJ, SC, TX, MA, MS, NH, WV, or DE (pharmacy partner is unlicensed there)
  • Headline prices are 'best rate' figures; standard monthly plans may cost more than the quarterly-plan rate shown
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path
  • Pharmacy partner's page notes it 'cannot dispense sterile compounds,' which is worth confirming for injectable GLP-1 fulfillment
PauseRX

Graded #150 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard